Research Analysts Set Expectations for CRSP Q3 Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Brookline Capital Management issued their Q3 2025 earnings estimates for shares of CRISPR Therapeutics in a report released on Tuesday, February 11th. Brookline Capital Management analyst L. Cann expects that the company will post earnings per share of ($0.94) for the quarter. The consensus estimate for CRISPR […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Brookline Capital Management issued their Q3 2025 earnings estimates for shares of CRISPR Therapeutics in a report released on Tuesday, February 11th. Brookline Capital Management analyst L. Cann expects that the company will post earnings per share of ($0.94) for the quarter. The consensus estimate for CRISPR […]
